Clinical Management of Coronavirus Disease 2019, Covid-19

  • Hayashi K
N/ACitations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

In December 2019, a novel coronavirus causing severe acute respiratory disease occurred in Wuhan, China. It is an emerging infectious disease with widespread and rapid infectiousness. The World Health Organization declared the coronavirus outbreak to be a public health emergency of international concern on 31 January 2020. Severe COVID-19 patients should be managed and treated in a critical care unit. Performing a chest X-ray/CT can judge the severity of the disease. The management of COVID-19 patients includes epidemiological risk and patient isolation; treatment entails general supportive care, respiratory support, symptomatic treatment, nutritional support, psychological intervention, etc. The prognosis of the patients depends upon the severity of the disease, the patient's age, the underlying diseases of the patients, and the patient's overall medical condition. The management of COVID-19 should focus on early diagnosis, immediate isolation, general and optimized supportive care, and infection prevention and control.Copyright © 2020 Wiley Periodicals LLC

Cite

CITATION STYLE

APA

Hayashi, K. (2020). Clinical Management of Coronavirus Disease 2019, Covid-19. Journal of Nihon University Medical Association, 79(6), 317–324. https://doi.org/10.4264/numa.79.6_317

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free